Answers are grounded in this paper and cite their sources.
The NR5A1 pre-mRNA can be spliced so that an upstream exon joins directly to exon 7, removing two or more internal exons and abolishing the full-length SF-1 receptor. The abundance of this splicing differs more than tenfold between human steroidogenic tissues. We asked what sets that level, using exon-exon junction counts for 1,054 GTEx samples of adrenal gland, ovary, pituitary and testis, with duplicated sample entries removed. The difference is not part of a genome-wide tendency to skip exons. A global skipping index built from the annotated junctions of 48 housekeeping genes was 1.16-fold higher in ovary than in adrenal (P = 6.3 × 10⁻¹³), against 11.3-fold for the NR5A1 index; expressed per sample relative to its own global index, ovary stood 9.9-fold above adrenal (P = 1.5 × 10⁻⁵⁷). Within every tissue the index rose as the mRNA abundance of CLK2, CLK4 and SRSF6 fell. Measured against a ten-gene housekeeping total and adjusted for junction depth, RNA integrity, ischaemic time and exonic mapping rate, the rank partial correlations ran from −0.18 to −0.34, all twelve with P < 0.002. That normaliser is itself related to the index in ovary (r = +0.29) and testis (+0.25) but not in adrenal gland (+0.06) or pituitary (+0.05), so the twelve tests were repeated against the 48-gene panel, total reads, mapped reads and the exon 6→7 junction, with and without the normaliser in the model. The direction held throughout, ten to twelve of twelve cells negative under every scheme. In adrenal gland and pituitary all three factors held under every scheme (−0.15 to −0.33, P ≤ 0.02); in ovary, where every candidate normaliser including total reads was related to the index, SRSF6 and CLK4 held (−0.20 to −0.31) and CLK2 did not; in testis, with library size as the normaliser, none of the three reached significance. CSNK2A1 was not associated in adrenal gland or ovary. The three factors did not track the global skipping index in a consistent direction, and their association with the NR5A1 index survived adjustment for it, so the effect is specific to NR5A1 rather than genome-wide. Because a skip index of s leaves a full-length share of 1/(1 + s), loss of functional SF-1 alone cannot lower a target gene by more than about 1% per percentage point of index. Associations with steroidogenic genes in adrenal exceeded that bound, ran in the wrong direction, and disappeared when CLK2, CLK4 and SRSF6 were added to the model; in ovary no association exceeded the bound. We therefore find no evidence that this splicing fine-tunes steroidogenesis through SF-1 dosage in normal tissue. In an unrelated public dataset, 64 RNA-seq runs of the adrenocortical carcinoma line NCI-H295R carried a skip index of 3.62%, against 0.90% for depth-matched GTEx adrenal tissue (P = 6.5 × 10⁻⁸), an independent confirmation that the junctions are present in this cell line.
No takes yet. Share an insight, caveat, or question.
Kenji Ohe (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: